Hypoglycaemia induced by hydroxychloroquine in a non-diabetic patient treated for RA.

[1]  J. Fries,et al.  Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis. , 2007, JAMA.

[2]  D. Gladman,et al.  Effect of antimalarial agents on the fasting lipid profile in systemic lupus erythematosus. , 2000, The Journal of rheumatology.

[3]  H. Gerstein,et al.  Insulin-sparing effect of hydroxychloroquine in diabetic rats is concentration dependent. , 1999, Canadian journal of physiology and pharmacology.

[4]  F. Jamali,et al.  Inhibition of insulin metabolism by hydroxychloroquine and its enantiomers in cytosolic fraction of liver homogenates from healthy and diabetic rats. , 1998, Life sciences.

[5]  M. Petri.  Biochemical characterization of ADP-ribose polymer metabolism in SLE. , 1996 .

[6]  D. Giugliano,et al.  Hydroxychloroquine in decompensated, treatment-refractory noninsulin-dependent diabetes mellitus. A new job for an old drug? , 1990, Annals of internal medicine.

[7]  O. Ekindjian,et al.  Modulation of Insulin Action on 2-Deoxyglucose Uptake by Chloroquine in Chick Embryo Fibroblasts , 1987, Diabetes.

[8]  K. Shojania,et al.  Hypoglycemia induced by hydroxychloroquine in a type II diabetic treated for polyarthritis. , 1999, The Journal of rheumatology.

[9]  M. Abu-Shakra,et al.  Hypoglycemia: an unusual adverse reaction to chloroquine. , 1994, Clinical and Experimental Rheumatology.

[10]  B. Furman,et al.  Chronic chloroquine treatment enhances insulin release in rats. , 1990, Diabetes research and clinical practice.